10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
56.09
-2.06 (-3.54%)
At close: Aug 14, 2026, 4:00 PM EDT
56.43
+0.34 (0.61%)
Pre-market: Aug 17, 2026, 8:17 AM EDT

10x Genomics Revenue

10x Genomics had revenue of $151.04M in the quarter ending June 30, 2026, a decrease of -12.65%. This brings the company's revenue in the last twelve months to $616.91M, down -4.28% year-over-year. In the year 2025, 10x Genomics had annual revenue of $642.82M with 5.25% growth.

Revenue (ttm)
$616.91M
Revenue Growth
-4.28%
P/S Ratio
11.85
Revenue / Employee
$523,694
Employees
1,178
Market Cap
7.31B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025642.82M32.04M5.25%
Dec 31, 2024610.79M-7.94M-1.28%
Dec 31, 2023618.73M102.32M19.81%
Dec 31, 2022516.41M25.92M5.28%
Dec 31, 2021490.49M191.65M64.13%
Dec 31, 2020298.85M52.95M21.53%
Dec 31, 2019245.89M99.58M68.06%
Dec 31, 2018146.31M75.23M105.83%
Dec 31, 201771.09M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.